The company reports that "participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery." Retatrutide is the latest compound to emerge from the revolution in hormonal treatment begun with the introduction of semaglutides like Ozempic in 2018 to treat Type 2 diabetes
Sometimes your insurance will send you a PA determination without sending it to us
In the U.S., Tirzepatide is available as: Mounjaro and Zepbound Throughout this article, any reference to Tirzepatide for weight loss refers to Zepbound
Another factor driving shortages: Medications like Adderall and amoxicillin generate thin profits so companies dont have an incentive to make and store large amounts in case a shortage develops, Fox said
Menopause transition is associated with changes in body composition including an increase in fat mass, a decrease in lean mass, and an increase in abdominal adiposity
Consult a qualified healthcare professional before using any product